Home › Pulmonary Arterial Hypertension › Nebraska › Omaha
Pulmonary Arterial Hypertension clinical trials in Omaha, NE
3 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 2
- University of Nebraska Medical Center - 2365, Omaha
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- USA028, Omaha
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RecruitingPhase 3
- University of Nebraska Medical Center, Omaha
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Dallas, TX4 studies
- Houston, TX4 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Cancer (all types)18 studies
- Colorectal Cancer18 studies
- Multiple Myeloma16 studies
- Ovarian Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Pancreatic Cancer14 studies
- Metastatic Cancer13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.